What is the appropriate titration schedule for starting amitriptyline in a patient with chronic vestibular migraine, including dose increments, timing, and monitoring?

How to Titrate Amitriptyline for Chronic Vestibular Migraine

Start amitriptyline at 25 mg at bedtime and increase by 10-25 mg every 2 weeks until reaching a goal dose of 75-150 mg daily or until therapeutic benefit is achieved without intolerable side effects 1.

Starting Dose and Initial Titration

Begin with 25 mg at bedtime 2, 3. However, in clinical practice, many patients with vestibular migraine tolerate and respond to lower starting doses. Real-world evidence shows that starting at 10 mg daily is common and effective, with 63% of headache patients in specialty practice beginning at this dose 4. For patients particularly sensitive to medication or concerned about side effects, you may consider starting as low as 5-10 mg 5.

The bedtime dosing is strategic—it leverages the sedative effect to improve sleep while minimizing daytime drowsiness, a common side effect 1, 2.

Titration Schedule

Increase the dose by 10-25 mg increments every 2 weeks 1. This slow titration is critical for tolerability. The 2024 AGA guideline on cyclic vomiting syndrome (which shares pathophysiology with vestibular migraine) explicitly states that "slow titration (10-25 mg increments, every 2 wk, up to goal dosage) is generally better tolerated" 1.

More aggressive titration schedules exist in older guidelines (25 mg every 3-7 days) 6, but the slower approach reduces dropout from side effects and is preferred in current practice.

Target Dose

The goal dose is 75-150 mg daily for most patients 1, 2, 3. However, real-world data reveals that many patients achieve therapeutic benefit at lower doses:

• Most patients in specialty practice remain on 10-25 mg daily (58% in one cohort) 4
• Approximately 75% of patients report improvement at these lower doses 4
• The traditional "therapeutic" doses of 30-150 mg cited in older guidelines 2, 3 may not be necessary for all patients with vestibular migraine

This discrepancy between guideline recommendations and clinical practice is important. While guidelines recommend 75-150 mg based on older migraine studies, vestibular migraine patients often respond to lower doses, possibly because the vestibular symptoms are more sensitive to tricyclic effects than headache alone.

Duration of Trial

Allow 2-3 months at the maximum tolerated dose before determining efficacy 2. Clinical benefits may not become apparent for 30 days or longer 7. This patience is essential—premature discontinuation is a common pitfall.

For vestibular migraine specifically, one study found that longer duration of vestibular symptoms before treatment was associated with better prophylactic response 8, suggesting that established VM may be particularly responsive to amitriptyline.

Monitoring and Adjustments

• Monitor for common side effects: somnolence, dry mouth, blurred vision, constipation, and weight gain 1
• Daytime fatigue is the most commonly reported adverse effect (11% of patients) 4
• Consider ECG monitoring for QTc prolongation, particularly at higher doses or in patients with cardiac risk factors 1
• If side effects occur, reduce the dose temporarily rather than discontinuing entirely

Special Considerations for Vestibular Migraine

Evidence specific to vestibular migraine shows that amitriptyline, propranolol, and flunarizine are equally effective for reducing vestibular symptoms, headache severity, and attack frequency 9, 8. The choice between these agents should be based on comorbidities and side effect profiles rather than efficacy differences.

For patients with comorbid anxiety, depression, or persistent postural-perceptual dizziness (PPPD), amitriptyline may be particularly appropriate 10. Conversely, if the patient has predominantly headache symptoms with less vestibular burden, other agents like topiramate might be considered 10.

Common Pitfalls to Avoid

1. Starting too high: Beginning at 25-50 mg may cause intolerable sedation; 10 mg is often better tolerated
2. Titrating too quickly: Increasing weekly rather than biweekly increases dropout rates
3. Stopping too soon: Waiting less than 2 months at therapeutic dose misses delayed responders
4. Assuming higher is better: Many VM patients respond to 10-25 mg; don't push to 150 mg unnecessarily
5. Ignoring anticholinergic effects: Elderly patients and those with glaucoma, urinary retention, or cognitive concerns need extra caution

Maintenance and Duration

Once therapeutic benefit is achieved, continue treatment for at least 3 months before considering dose reduction 2. After a period of stability (typically 6-12 months), you may attempt gradual tapering to the lowest effective maintenance dose, which may be as low as 10-25 mg daily 4.

85% of patients remain on amitriptyline at follow-up in specialty practice, indicating good long-term tolerability when properly titrated 4.